NF κB is a primary regulator for proinflammatory gene expression and inhibition of the NFκB inflammatory activation has been shown to improve insulin sensitivity and cardiovascular injury in metabolic and hypertensive diseases [17,20]. This evidence concerns the gene NFKB1 and hypertensive disorder.